222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 285 / 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02399462 (ClinicalTrials.gov)	March 2021	8/1/2015	Acthar for Treatment of Post-transplant FSGS	Acthar for Treatment of Post-transplant FSGS	FSGS;Renal Transplantation;Kidney Transplantation	Drug: Acthar	University of North Carolina, Chapel Hill	Mallinckrodt	Withdrawn	18 Years	N/A	All	0	Phase 4	United States
2	NCT02683889 (ClinicalTrials.gov)	February 1, 2019	5/2/2016	Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation	The Use of Acthar(ACTH) in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Have Develope ...	FSGS	Drug: Acthar	University of Colorado, Denver	NULL	Recruiting	18 Years	80 Years	All	20	Phase 3	United States
3	NCT03025828 (ClinicalTrials.gov)	March 19, 2018	17/1/2017	Adrenocorticotropic Hormone in Membranous Nephropathy	Changes in Autoreactive Memory B Cells as Biomarker of Response to Adrenocorticotropic Hormone in Pa ...	Membranous Nephropathy	Drug: ACTHar	Icahn School of Medicine at Mount Sinai	NULL	Completed	18 Years	70 Years	All	5	Phase 4	United States
4	NCT02633046 (ClinicalTrials.gov)	October 10, 2016	15/12/2015	Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria	Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segment ...	Idiopathic Focal Segmental Glomerulosclerosis	Drug: Acthar Gel	Mallinckrodt ARD LLC	NULL	Completed	18 Years	N/A	All	63	Phase 4	United States;Argentina;Australia;Chile;Mexico;Peru;Turkey;Canada;Hong Kong;New Zealand;Puerto Rico
5	NCT01386554 (ClinicalTrials.gov)	August 2011	29/6/2011	Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients	A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study of H.P. ActharGel (Acthar) in T ...	Proteinuria;Idiopathic Membranous Nephropathy	Drug: Repository Corticotropin Injection;Drug: Placebo	Mallinckrodt	NULL	Completed	18 Years	N/A	All	60	Phase 4	United States;Canada;Chile;Mexico;Turkey
6	NCT01155141 (ClinicalTrials.gov)	September 2009	29/6/2010	Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH	Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH	Kidney Diseases	Drug: H.P. Acthar Gel	Stanford University	Mallinckrodt	Completed	16 Years	65 Years	All	15	Phase 4	United States

First Previous1Next Last